AugmentRx™

AugmentRx™ Medical Technologies, Inc. of Shelburne, Vermont was founded by Stuart K. J. Smyth and his partners, a team of seasoned business and medical professionals in 2005.

The company, AugmentRx™ was created to treat of urinary and bowel incontinence in women and men. Worldwide, there are over 200 million people who suffer from urinary incontinence, while over 25 million suffer from bowel incontinence. With AugmentRx™, the core materials are all FDA cleared and the medical research team has determined that the AugmentRx™ SOLVE Injectable composite, consisting of microporous spheres, has both the properties and characteristics of the long awaited “ideal” tissue bulking material. The material is nonmigratory, nonantigenic and provides sustainable tissue volume. Because the materials are bioinert, microporous ceramic spheres or scaffolds, the product tends to demonstrate a superior technology when compared to other competing medical technologies in this field.

The AugmentRx™ goal of solving a sensitive medical condition proves to be cost effective for the patients and healthcare systems. The AugmentRx™ SOLVE Injectable can be performed in a doctor’s office or Outpatient Clinic under local anesthesia, and is designed specifically to be safe, reliable, quick and a simple procedure. It takes only 5 to 10 minutes to complete.

The purpose of the AugmentRx™ SOLVE Injectable is to restore dignity in patients in order to immediately resume normal every day activities.